Endocyte, Inc. – Product Pipeline Review – Q2 2011 by GlobalMarketsDirect

VIEWS: 3 PAGES: 53

Endocyte, Inc. – Product Pipeline Review – Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Endocyte, Inc. - Product Pipeline Review - Q2 2011” provides data on the Endocyte, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Endocyte, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Endocyte, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Endocyte, Inc. - Brief Endocyte, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Endocyte, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Endocyte, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Endocyte, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Endocyte, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Endocyte, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Endocyte, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunit

More Info
									     Endocyte, Inc. – Product Pipeline Review – Q2 2011

                                                                                          Reference Code: GMDHC1284CDB


                                                                                               Publication Date: JULY 2011




Endocyte, Inc. – Product Pipeline Review – Q2 2011                                         GMDHC1284CDB / Published JULY 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Endocyte, Inc. – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                      2
List of Tables                                                                                                         4
List of Figures                                                                                                        5
Endocyte, Inc. Snapshot                                                                                                6
    Endocyte, Inc. Overview                                                                                            6
    Key Information                                                                                                    6
    Key Facts                                                                                                          6
Endocyte, Inc. – Research and Development Overview                                                                     7
    Key Therapeutic Areas                                                                                              7
Endocyte, Inc. – Pipeline Review                                                                                      10
    Pipeline Products by Stage of Development                                                                         10
    Pipeline Products – Monotherapy                                                                                   11
    Pipeline Products – Combination Treatment Modalities                                                              12
Endocyte, Inc. – Pipeline Products Glance                                                                             13
    Endocyte, Inc. – Late Stage Pipeline                                                                              13
         Phase III Products/Combination Treatment Modalities                                                          13
    Endocyte, Inc. Clinical Stage Pipeline Products                                                                   14
         Phase I Products/Combination Treatment Modalities                                                            14
    Endocyte, Inc.–Early Stage Pipeline Products                                                                      15
         Pre-Clinical Products/Combination Treatment Modalities                                                       15
         Discovery Products/Combination Treatment Modalities                                                          16
Endocyte, Inc. – Drug Profiles                                                                                        17
    EC145                                                                                                             17
         Product Description                                                                                          17
         Mechanism of Action                                                                                          17
         R&D Progress                                                                                                 17
    EC145 + Doxil                                                                                                     18
         Product Description                                                                                          18
         Mechanism of Action                                                                                          18
         R&D Progress                                                                                                 18
    EC0225                                                                                                            19
         Product Description                                                                                          19
         Mechanism of Action                                                                                          19
         R&D Progress                                                                                                 19
    EC0489                                                                                                            20
         Product Description                                                                                          20
         Mechanism of Action                                                                                          20
         R&D Progress                                                                                                 20
    EC0482                                                                                                            21
         Product Description                                                                                          21
         Mechanism of Action                                                                                          21
         R&D Progress                                                                                                 21
    EC0531                                                                                                            22
         Product Description                                                                                          22
         Mechanism of Action                                                                                          22
         R&D Progress                                                                                                 22




Endocyte, Inc. – Product Pipeline Review – Q2 2011                                        GMDHC1284CDB / Published JULY 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                              Page(2)
Endocyte, Inc. – Product Pipeline Review



    EC0565                                                                                                            23
         Product Description                                                                                          23
         Mechanism of Action                                                                                          23
         R&D Progress                                                                                                 23
    EC0746                                                                                                            24
         Product Description                                                                                          24
         Mechanism of Action                                                                                          24
         R&D Progress                                                                                                 24
    EC1069                                                                                                            25
         Product Description                                                                                          25
         Mechanism of Action                                                                                          25
         R&D Progress                                                                                                 25
    ECO531                                                                                                            26
         Product Description                                                                                          26
         Mechanism of Action                                                                                          26
         R&D Progress                                                                                                 26
    EC0845                                                                                                            27
         Product Description                                                                                          27
         Mechanism of Action                                                                                          27
         R&D Progress                                                                                                 27
Endocyte, Inc. – Pipeline Analysis                                                                                    28
    Endocyte, Inc. – Pipeline Products by Therapeutic Class                                                           28
    Endocyte, Inc. - Pipeline Products By Target                                                                      30
    Endocyte, Inc. – Pipeline Products by Route of Administration                                                     31
    Endocyte, Inc. – Pipeline Products by Molecule Type                                                               32
Endocyte, Inc. – Recent Pipeline Updates                                                                              33
Endocyte, Inc. - Dormant Projects                                                                                     34
Endocyte, Inc. - Discontinued Pipeline Products                                                                       35
    Discontinued Pipeline Product Profiles                                                                            35
         EC17                                                                                                         35
         EC90 + EC17+ GPI-0100 + IL-2 + IFN-alpha                                                                     35
Endocyte, Inc. – Locations And Subsidiaries                                                                           36
    Head Office                                                                                                       36
    Other Locations & Subsidiaries                                                                                    36
Financial Deals Landscape                                                                                             37
    Endocyte, Inc., Deals Volume Summary, 2004 to YTD 2011                                                            37
    Endocyte, Inc., Deals Summary By Region, 2004 to YTD 2011                                                         38
    Endocyte, Inc., Deals Summary, 2004 to YTD 2011                                                                   39
    Endocyte, Inc. Detailed Deal Summary                                                                              40
         Venture Financing                                                                                            40
         Endocyte Secures $26 Million In Series C-4 Round                                                             40
         Endocyte Secures $15 Million In Series C-3 Financing                                                         42
         Endocyte Secures $23 Million In Series C-2 Fin
								
To top